Form 8-K · Current Report · Filed 2026-04-23
IQVIA Holdings Inc. Adopts New 2026 Incentive and Stock Award Plan
IQVIA Holdings Inc. has adopted the 2026 Incentive and Stock Award Plan, which replaces the 2017 Plan and authorizes a range of performance- and time-based equity-based awards. The plan was approved by stockholders at the 2026 Annual Meeting, which also saw the election of directors and the ratification of the independent auditor. The new plan includes stock options, stock appreciation rights, restricted stock awards, restricted stock units, and stock awards, with vesting based on company performance metrics and continued employment.
- Filer
- Iqvia Holdings Inc. IQV · NYSE
- Filed
- Accession
- 0001193125-26-173771
- CIK
- 0001478242
- Signal
- Medium impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$175.21
Next session
-7.4%
Since filing
+34.1%
Latest close
$235.02
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from IQV reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, IQV insiders reported 4 Form 4 transactions — net buying of $143K.
About Iqvia Holdings Inc.
Iqvia Holdings Inc. is a leading global provider of advanced analytics, technology solutions, and contract research services. Its primary function is to support the healthcare sector by offering data-driven insights and innovations that underpin strategic decision-making across pharmaceutical, biotechnology, and medical device industries. Iqvia plays a crucial role in facilitating drug development through its comprehensive clinical research capabilities, encompassing everything from clinical trials to regulatory submissions. Additionally, its technology solutions leverage artificial intelligence and machine learning to optimize clinical and commercial operations, contributing to enhanced patient outcomes and streamlined healthcare delivery. Iqvia's integrated services impact sectors such as drug safety, patient engagement, and real-world evidence, making it an indispensable partner for healthcare companies seeking to navigate complex markets and regulatory environments. Globally recognized for its vast data repository and cutting-edge analytical platforms, Iqvia serves as a pivotal player in the transformation of the healthcare landscape, empowering organizations to accelerate innovation and improve patient care.
Never miss another IQV filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.